Good Clinical Practice (GCP), the bedrock of ethical ... However, like other aspects of drug development, it is evolving. The International Council for Harmonisation of Technical Requirements ...

To understand the value of a company's earnings growth, it is imperative to consider any dilution of shareholders' interests. UOA Development Bhd expanded the number of shares on issue by 5.4% over ...

The RM1.96 analyst price target for UOADEV is 38% more than our estimate of fair value Does the November share price for UOA Development Bhd (KLSE:UOADEV) reflect what it's really worth?

As the Practice Development Nurse (RAC), you will be responsible for supporting the standard of clinical practice for all nurses in the SVHM RAC program with educational sessions, coaching and local ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Drug Development Unit (DDU) provides clinical research services and support to the faculty of the School of Medicine and to pharmaceutical sponsors. Our team of experienced investigators, nurses, ...

Credit: Drop of Light / Shutterstock. Generative artificial intelligence (GenAI) has the potential to revolutionise clinical development – and certain key steps will help to unlock its full impact – ...

KUALA LUMPUR: UOA Development Bhd recorded a net profit of RM48.34mil in the third-quarter ended Sept 30, 2024, down from RM50.86mil in the year-ago quarter, which translates to an earnings per ...

The RM1.96 analyst price target for UOADEV is 38% more than our estimate of fair value Does the November share price for UOA Development Bhd (KLSE:UOADEV) reflect what it's really worth? Today, we ...